1/3

FIEO Registered Export Ready

Voglibose, Glimepiride &Metformin Hydrochloride(Sustained Release) Tablets

Name: Voglibose, Glimepiride &Metformin Hydrochloride(Sustained Release) Tablets
Brand: indiglobal exports
SKU: 8520227
Availability: InStoreOnly

Sold by indiglobal exports · Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

Price

Price on request

In stock

Minimum order: 1 unit

Export Snapshot

MOQ

1 unit

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for indiglobal exports.

Compliance & Certifications

FIEO Registered

Suitable for

Importers · Distributors · Wholesalers

Panchkula Dispatch on request FIEO member

indiglobal exports

Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

We are a distinguished merchant trading and export company, specializing in the international supply of premium-quality products across various sectors. Our portfolio includes pharmaceuticals, marketed under a neutral code, as well as millets, mango pulp, compounded animal and livestock feed, and orthopaedic appliances. We take great pride in our meticulous product selection and procurement processes, consistently adhering to the highest standards of quality assurance to ensure the delivery of superior goods to our clients.

Registered address: Chandigarh, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Medical Equipment & Supplies.

View profile All products

Established

2024

Employees

1–10

GST

06EOGPS3248L1ZF

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Apr 2024

Turnover

2500001 - 10000000.

Incorporation Type

On request

Verified Seller IEC Certificate GST Certificate UDYAM Registration Certificate

Product details

What are the specifications of this product?

Overview

Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets is a pharmaceutical product indicated for diabetes treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations. Features: Used in the management of diabetes conditions Precise dosage form and active pharmaceutical ingredients Suitable for international pharmaceutical markets Manufactured in GMP-compliant facilities Reliable therapeutic performance Attributes: Category: Diabetes Formulation: Tablet Packaging: Export-grade blister or strip packs Shelf Life: As per regulatory standards Manufacturer: IndiGlobal Exports

Product Description

Product Overview

Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets is developed for the effective management of diabetes conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.

Therapeutic Use & Application

This formulation supports the clinical treatment and ongoing care of patients with diabetes indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.

Formulation & Packaging

Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.

Quality & Compliance

The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.

Description provided by indiglobal exports.

Specifications

Category	Diabetes Management
Therapeutic Class	Antidiabetic Combination
Active Pharmaceutical Ingredients (APIs)	Voglibose, Glimepiride, Metformin Hydrochloride
Sustained Release	Yes, formulated for extended glucose control
Tablet Weight	As per manufacturer’s specification
Packaging Options	Blister packs or strip packs suitable for bulk export
Shelf Life	Compliant with export regulatory norms (typically 24 months)
Storage Conditions	Store in a cool, dry place away from direct sunlight
Compliance	Manufactured under WHO-GMP, IP/USP standards
Intended Use	For clinical treatment and ongoing diabetes care

Use cases

Category	Pharmaceuticals > Diabetes Medications > Combination Antidiabetic Tablets
Primary application	Wholesale, distribution, and international sourcing
Brand	indiglobal exports
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Voglibose, Glimepiride &Metformin Hydrochloride(Sustained Release) Tablets. Answers compiled from verified sellers' commercial terms and platform data.

Q: What is the advantage of the sustained-release formulation in these tablets?

A: The sustained-release formulation ensures gradual and controlled release of Voglibose, Glimepiride, and Metformin Hydrochloride, resulting in prolonged blood glucose control and improved patient compliance by reducing dosing frequency.

Q: Are these tablets compliant with international manufacturing regulations?

A: Yes, the tablets are manufactured in WHO-GMP compliant facilities and adhere to IP/USP pharmacopoeial standards, ensuring quality and compliance for international pharmaceutical markets.

Q: What packaging options are available for bulk exports?

A: The product is packaged in export-grade blister or strip packs, suitable for bulk shipments and institutional supply chains to meet export market requirements.

Q: Can this combination therapy be prescribed in both hospital and retail settings?

A: Yes, the tablets are suitable for prescription use in hospitals as well as retail pharmacies, facilitating broad accessibility for diabetes treatment.

Q: What are the storage recommendations for these tablets to maintain efficacy?

A: The tablets should be stored in a cool, dry place away from direct sunlight, following the recommended storage conditions to preserve quality and shelf life.

Question not answered? Ask sellers directly — typical response within 4 hours.